Is Less More: Does Leukopenia Predict Remission in Patients with Inflammatory Bowel Disease Receiving Thiopurine Treatment?

被引：2
|
作者：
Gisbert, Javier P. [1 ,2 ]
机构：
[1] Hosp Univ La Princesa, Gastroenterol Unit, Inst Invest Sanitaria Princesa, Madrid 28669, Spain
[2] Hosp Univ La Princesa, Ctr Invest Biomed Red Enfermedades Hepaticas & Di, Madrid 28669, Spain
来源：
DIGESTIVE DISEASES AND SCIENCES | 2015年 / 60卷 / 01期
关键词：
AZATHIOPRINE THERAPY; 6-MERCAPTOPURINE; NEUTROPENIA;
D O I：
10.1007/s10620-014-3481-z
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：4 / 6
页数：3
相关论文
共 50 条
  • [1] Is Less More: Does Leukopenia Predict Remission in Patients with Inflammatory Bowel Disease Receiving Thiopurine Treatment?
    Javier P. Gisbert
    Digestive Diseases and Sciences, 2015, 60 : 4 - 6
  • [2] Leukopenia Predicts Remission in Patients with Inflammatory Bowel Disease and Behcet's Disease on Thiopurine Maintenance
    Park, Mi Sung
    Kim, Dong Hyun
    Kim, Duk Hwan
    Park, Soo Jung
    Hong, Sung Pil
    Kim, Tae Il
    Kim, Won Ho
    Cheon, Jae Hee
    DIGESTIVE DISEASES AND SCIENCES, 2015, 60 (01) : 195 - 204
  • [3] Leukopenia Predicts Remission in Patients with Inflammatory Bowel Disease and Behcet’s Disease on Thiopurine Maintenance
    Mi Sung Park
    Dong Hyun Kim
    Duk Hwan Kim
    Soo Jung Park
    Sung Pil Hong
    Tae Il Kim
    Won Ho Kim
    Jae Hee Cheon
    Digestive Diseases and Sciences, 2015, 60 : 195 - 204
  • [4] Early assessment of thiopurine metabolites predicts the occurrence of leukopenia in inflammatory bowel disease patients
    Wong, D.
    Coenen, M.
    Derijks, L.
    van Marrewijk, C.
    Vermeulen, S.
    Verbeek, A.
    Franke, B.
    Guchelaar, H. -J.
    De Jong, D.
    Engels, L.
    Hooymans, P.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S31 - S32
  • [5] Measurement of thiopurine metabolites concentrations after one week of treatment does not predict treatment failure in Inflammatory Bowel Disease patients
    Deben, D.
    Van Moorsel, F.
    Creemers, R.
    Winkens, B.
    Bus, P.
    Pierik, M.
    Simsek, M.
    De Boer, N.
    Wong, D.
    Van Bodegraven, A.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I480 - I481
  • [6] Early Assessment of Thiopurine Metabolites Identifies Patients at Risk of Thiopurine-induced Leukopenia in Inflammatory Bowel Disease
    Wong, Dennis
    Coenen, Marieke
    Vermeulen, Sita
    Derijks, Luc
    van Marrewijk, Corine
    Klungel, Olaf H.
    Scheffer, Hans
    Franke, Barbara
    Guchelaar, Henk-Jan
    de Jong, Dirk
    Engels, Leopold
    Verbeek, Andr
    Hooymans, Piet
    JOURNAL OF CROHNS & COLITIS, 2017, 11 (02): : 175 - 184
  • [7] Measurement of thiopurine metabolites concentrations after one week of treatment does not predict treatment failure in Inflammatory Bowel Disease patients
    Deben, D.
    Van Moorsel, F.
    Creemers, R.
    Winkens, B.
    Bus, P.
    Pierik, M.
    Simsek, M.
    De Boer, N.
    Wong, D.
    Van Bodegraven, A.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I480 - I481
  • [8] Thiopurine Treatment in Inflammatory Bowel Disease
    Sharon J. Gardiner
    Evan J. Begg
    Ashis Sau
    Anthony Marinaki
    Richard B. Gearry
    Murray L. Barclay
    Clinical Pharmacokinetics, 2007, 46 : 803 - 804
  • [9] Thiopurine treatment in inflammatory bowel disease
    Gardiner, Sharon J.
    Begg, Evan J.
    Sau, Ashis
    Marinaki, Anthony
    Gearry, Richard B.
    Barclay, Murray L.
    CLINICAL PHARMACOKINETICS, 2007, 46 (09) : 803 - 804
  • [10] Fecal Calprotectin Does Not Predict Endoscopic Remission in Inflammatory Bowel Disease
    Falvey, James D.
    Gearry, Richard B.
    Day, Andrew S.
    INFLAMMATORY BOWEL DISEASES, 2013, 19 (06) : E80 - E81
12345